Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Economist Intelligence Unit (EIU) is the research and analysis division of The Economist Group, providing forecasting and advisory services to businesses, financial institutions, and governments. Within the life sciences sector, EIU Healthcare offers specialized market intelligence, value-based medicine analysis, and strategic consulting for pharmaceutical, biotechnology, and medtech companies. Their services include disease burden modeling, market access strategy, and evidence-based health policy research. The company leverages global data and expert analysis to help healthcare stakeholders navigate complex regulatory and economic environments worldwide. EIU is particularly known for its 'Quality of Death' index and various healthcare outcome rankings that influence global health policy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Economist Intelligence Unit.